The Queen (on the application of Napp Pharmaceuticals Ltd) v Secretary of State for Health acting as the Licensing Authority Sandoz Ltd (Interested Party)

Core Citations

REFERS TO

• Napp Pharmaceutical Holdings Ltd v Dr Reddy's Laboratories (UK) Ltd and Another

CONSIDERS

• Merck Sharp & Dohme Ltd, R v Licensing Authority and Others
• Medicines Act 1968
• Medicines Act 1968

REPORTED OPINION OF in

• [2016] All ER D 194 Jul
• 152 BMLR 172

This document cites

• Napp Pharmaceutical Holdings Ltd v Dr Reddy's Laboratories (UK) Ltd and Another
• Merck Sharp & Dohme Ltd, R v Licensing Authority and Others
• Medicines Act 1968
• The Human Medicines Regulations 2012
• The Queen v The Licensing Authority established by the Medicines Act 1968 (acting by The Medicines Control Agency), ex parte Generics (UK) Ltd, The Wellcome Foundation Ltd and Glaxo Operations UK Ltd and Others.



See all quotations

• The Queen, on the application of Novartis Pharmaceuticals UK Ltd v The Licensing Authority established by the Medicines Act 1968 (acting by the Medicines Control Agency).
• The Queen, on the application of Synthon BV v Licensing Authority of the Department of Health.
• The Queen, on the application of Approved Prescription Services Ltd v Licensing Authority.
• Temco Service Industries SA v Samir Imzilyen and Others.
• Christopher Sturgeon, Gabriel Sturgeon and Alana Sturgeon v Condor Flugdienst GmbH (C-402/07) and Stefan Böck and Cornelia Lepuschitz v Air France SA (C-432/07).
• Council Regulation (EEC) No 1768/92 of 18 June 1992 concerning the creation of a supplementary protection certificate for medicinal products
• Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use
• Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) No 726/2004 (Text with EEA relevance)
• Council Directive 65/65/EEC of 26 January 1965 on the approximation of provisions laid down by Law, Regulation or Administrative Action relating to proprietary medicinal products
• Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Union procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency (Text with EEA relevance)Text with EEA relevance
• Regulation (EC) No 1394/2007 of the European Parliament and of the Council of 13 November 2007 on advanced therapy medicinal products and amending Directive 2001/83/EC and Regulation (EC) No 726/2004 (Text with EEA relevance)
• Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004 amending Directive 2001/83/EC on the Community code relating to medicinal products for human use (Text with EEA relevance)